THE INCIDENCE OF RETINOPATHY OF PREMATURITY AND STEROID-THERAPY FOR BRONCHOPULMONARY DYSPLASIA

To determine whether prolonged dexamethasone therapy, used in the trea tment of bronchopulmonary dysplasia (BPD), affects the incidence of re tinopathy of prematurity (ROP), premature born infants (Gestational ag e < 33 weeks) treated or not with dexamethasone for BPD were retrospec tively studied over a 5 pear period. Although the dexamethasone treate d group had a significant lower gestational age and a longer period of total ventilatory support there was no significant difference in inci dence of ROP between the groups.